Abstract
It has been shown that there are important differences between fenfluramine hydrochloride and the traditional stimulant drugs used in treating obesity. The stimulant anorexiants are believed to act via central catecholamine mechanisms whereas fenfluramine appears to act via serotonergic mechanisms. The traditional stimulant drugs have adverse effects including insomnia, nervousness, increased motor activity, and occasional cardiovascular disturbances including increased pulse rate and increased blood pressure. They also appear to delay the onset of eating and to shorten its duration. Fenfluramine often causes sedative effects and occasionally diarrhea.
Weintraub, M., Hasday, J., Mushlin, A., & Lockwood, D. (1984). A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Archives of Internal Medicine, 144(6), 1143–1148. doi: 10.1001/archinte.144.6.1143
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/604539
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Connolly H, et al. Valvular heart disease associated with fenfluramine–phentermine. N Engl J Med. 1997;337(24):1772–6. https://doi.org/10.1056/nejm199712113372414.
Anti-obesity drugs recalled from global market. Lancet. 1997;350(9081):867. https://doi.org/10.1016/s0140-6736(97)23038-2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kalinowski, A. (2023). Phen/Fen for Weight Loss-1984. In: Russell, J., Skolnik, N.S. (eds) Top Articles in Primary Care. Springer, Cham. https://doi.org/10.1007/978-3-031-25620-2_43
Download citation
DOI: https://doi.org/10.1007/978-3-031-25620-2_43
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-25619-6
Online ISBN: 978-3-031-25620-2
eBook Packages: MedicineMedicine (R0)